Aquapharm Strengthens Management Team with Appointment of New Chairman and CFO

16-Mar-2009 - United Kingdom

Aquapharm Biodiscovery announced the appointment of Steve Harris as non-executive Chairman of the board, with immediate effect. Mr. Harris replaces Ron James, the outgoing chairman, who is retiring. The Company also announces the appointment of Sandy McDougall as Chief Financial Officer.

Mr. Harris has over 40 years experience in the pharmaceutical and biotech industry having worked with a number of public and private companies and gained extensive know-how in the areas of business development, licensing and financing. As Chairman of Aquapharm’s board, he will guide and contribute to the ongoing development of the Company, both in terms of future financing and also as Aquapharm drives forward the discovery and development of its products. He is currently non-executive Chairman of UK-based companies Proteome Sciences plc and Cyprotex plc and a non-executive Director at Advanced Medical Solutions Group plc.

Prior to joining Aquapharm, Mr. Harris has held a number of non-executive directorships, including at Sinclair Pharma plc and Skye Pharma plc. From 1990-1995 he was Director of Development and Licensing at Medeva plc where he was instrumental in many of the licensing and acquisition deals conducted during the period. Earlier in his career Mr. Harris held a variety of sales, marketing and general management positions in multinational companies, including ICI (now AstraZeneca), Merck Sharpe & Dohme, Eli Lilly, Boots, and Reckitt & Colman.

In addition, Sandy McDougall has been appointed as Chief Financial Officer. Mr. McDougall joins Aquapharm from Healthcare software provider Craneware plc, where in his position as CFO, he saw the company through a successful and award-winning IPO on AIM in 2007. Mr. McDougall brings extensive experience in fundraising, IPOs and M&A having worked in the life sciences sector for the past 10 years. During this time Mr. McDougall served as CFO and later as a non-executive director of PanTherix Ltd.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances